About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prognostic Significance of the Uncertain Resection in NSCLC

NCT06511661·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sun Yat-sen University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Primary non-small cell lung cancer
2. With pulmonary resection

You may not be if

1. Sublobar resection
2. R1/R2
3. Positive highest mediastinal lymph nodes
4. Operative death

The record

StatusUnknown

PhaseNo phase

Taking part3,783

StartedJul 2024

UpdatedJul 25, 2024

Conditions

Non Small Cell Lung Cancer Residual; State

Where1

Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China

Clareo Health | Prognostic Significance of the Uncertain Resection in NSCLC